pantoprazole has been researched along with Bronze Diabetes in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moris, W | 1 |
| Verhaegh, PLM | 1 |
| Verbeek, J | 1 |
| Swinkels, DW | 1 |
| Laarakkers, CM | 1 |
| Masclee, AAM | 1 |
| Koek, GH | 1 |
| Deursen, CTBMV | 1 |
| Vanclooster, A | 1 |
| van Deursen, C | 1 |
| Jaspers, R | 1 |
| Cassiman, D | 1 |
| Koek, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757] | 48 participants (Anticipated) | Interventional | 2012-03-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pantoprazole and Bronze Diabetes
| Article | Year |
|---|---|
Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Double-Blind Method; Female; Ferritins; Hemochromato | 2017 |
1 other study available for pantoprazole and Bronze Diabetes
| Article | Year |
|---|---|
Absorption of nonheme iron during gastric acid suppression in patients with hereditary hemochromatosis and healthy controls.
Topics: Adult; Body Mass Index; Female; Ferritins; Hemochromatosis; Hepcidins; Humans; Iron; Male; Middle Ag | 2021 |